The Effect of a Hybrid Approach in Breast Cancer Education on Women's Awareness, Fatalism, and Self-Compassion Levels: A Randomized Controlled Trial

NCT07828119 | Not Yet Recruiting

• 1 other identifier: KSU-TAREK-244
• Study Type: interventional
• Target: 128
• Locations: 1 country
• Sites: 1

Brief Summary

This randomized controlled trial aims to evaluate the effect of a hybrid breast cancer education program on women's breast cancer awareness, cancer fatalism, and self-compassion levels. The study will include 128 women aged 20-65 who apply to an obstetrics and gynecology outpatient clinic. Participants will be randomly assigned to either an experimental group or a control group. The experimental group will receive a hybrid education model. This model consists of a face-to-face training session using a breast model, followed by four weeks of educational materials, informative messages, and reminders delivered via a mobile application. The control group will receive routine healthcare services without this specific educational intervention. Researchers will measure the participants' levels of self-compassion, breast cancer fatalism, and breast cancer awareness using standardized questionnaires. These measurements will be taken at the beginning of the study (pre-test) and four weeks later (post-test) to determine if the technology-supported hybrid education model is effective in improving early diagnosis awareness and psychosocial outcomes

Conditions

Breast Cancer Awareness

Keywords

Breast Cancer Awareness; Cancer Fatalism; Self-Compassion; Hybrid Education

Outcome Measures

Primary Outcomes (1)

• Breast Cancer Awareness Score

  Change in participants' breast cancer awareness scores from baseline to 4 weeks post-intervention.

  Baseline and 4 weeks post-intervention

Study Arms (2)

Hybrid Breast Cancer Education Group

EXPERIMENTAL

The experimental group will receive a hybrid breast cancer education model consisting of a face-to-face training session using a breast model, followed by educational materials, informative messages, and reminders delivered via a mobile application over a four-week period.

Behavioral: Hybrid Breast Cancer Education

Control Group

NO INTERVENTION

Participants in the control group will not receive the hybrid breast cancer education intervention during the study period.

Interventions

Hybrid Breast Cancer Education BEHAVIORAL

The experimental group will receive a hybrid breast cancer education model consisting of a face-to-face training session using a breast model, followed by educational materials, informative messages, and reminders delivered via a mobile application over a four-week period

Hybrid Breast Cancer Education Group

Eligibility Criteria

• Age: 20 Years - 65 Years
• Gender Eligibility Details: Only female participants are eligible to participate in this study.
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Being between 20 and 65 years of age
• Being female
• Agreeing to participate in the study and signing the informed consent form
• Having no prior diagnosis of breast cancer
• Having the ability to use a mobile application

You may not qualify if:

• Having a prior diagnosis of breast cancer or active breast pathology
• Having any cognitive, mental, or communication barrier that prevents participation in training
• Refusing to participate or withdraw consent during the study

Sponsors & Collaborators

• Kahramanmaras Sutcu Imam University: lead

Study Sites (1)

Kahramanmaras Sutcu Imam University Hospital, Department of Obstetrics and Gynecology, Delivery Room

Kahramanmaraş, Merkez, 46040, Turkey (Türkiye)

Location

Central Study Contacts

Emine A AKSÜT AKÇAY, Assistant Professor

CONTACT

0553594 52 60; emineaksutakcay@ksu.edu.tr/

Hülya KAMALAK, Master's Student

CONTACT

0553594 52 60; hulyakoca31@windowslive.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Asst. Prof. Dr.

Model Details: Participants will be randomly assigned to one of two parallel groups in a 1:1 ratio: an experimental group receiving the hybrid breast cancer education model, and a control group receiving standard routine care.

Study Record Dates

• First Submitted: September 3, 2026
• First Posted: September 18, 2026
• Study Start: September 15, 2026
• Primary Completion (Estimated): December 31, 2026
• Study Completion (Estimated): December 31, 2026
• Last Updated: September 18, 2026

Record last verified: 2026-09

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)